Physician profile
Jerrold D Cantor
NPI 1063547792
$1,849.62
in general payments reported to CMS, 2019-2025
15 companies · $422 in 2025
The $422 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.22 · 2020: $348 · 2021: $219 · 2022: $110 · 2023: $257 · 2024: $432 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,110.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $283.27 | 2022-2025 | Repatha, Repatha |
| Biotronik INC. | $281.22 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $266.42 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $226.15 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.33 | 2020-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $125.35 | 2021-2025 | Verquvo, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $109.59 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $76.77 | 2023-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $63.63 | 2022-2025 | Eliquis |
| Pfizer INC. | $52.39 | 2024 | |
| Edwards Lifesciences Corporation | $45.39 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi-Aventis U.S. LLC | $36.59 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.33 | 2023 | Lifevest |
| Scpharmaceuticals INC. | $29.13 | 2024 | |
| Glaxosmithkline, LLC. | $22.06 | 2025 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerrold Cantor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.